A recent study suggests that using the weight loss medication Ozempic (liraglutide) may reduce migraine frequency by as much as 50% in people who suffer from chronic or frequent migraines. Researchers gave 31 obese adults with migraines liraglutide and found that their average number of migraine days decreased from 20 to 11, a significant reduction.
The study’s lead author, Dr. Simone Braca, believes that liraglutide alleviates pressure on the cerebrospinal fluid, which cushions the brain and spine. This pressure buildup can trigger migraines. By targeting this mechanism, Dr. Braca suggests that it may be possible to prevent migraines altogether.
The study’s findings have significant implications for the 47 million Americans who suffer from migraines. The condition is characterized by throbbing pain, usually on one side of the head, and can be triggered by various factors such as stress, hormonal fluctuations, sleep issues, and certain foods or drinks.
While the study shows promise, it is essential to note that more research is needed to fully understand the long-term effects of liraglutide on migraine prevention. However, this breakthrough may offer new hope for millions of people suffering from severe headaches.
Source: https://www.dailymail.co.uk/health/article-14860907/ozempic-effect-revealed-slash-migraine-research.html